Late presentation in HIV-infected injecting drug users - a huge challenge for the Romanian health-care system

被引:4
|
作者
Ianache, Irina [1 ]
Calistru, Petre [1 ,2 ]
Tardei, Gratiela [1 ]
Ruta, Simona [2 ,3 ]
Oprea, Cristiana [1 ,2 ]
机构
[1] Victor Babes Clin Hosp Infect & Trop Dis, Bucharest, Romania
[2] Carol Davila Univ Med & Pharm, Bucharest, Romania
[3] Stefan S Nicolau Inst Virol, Bucharest, Romania
来源
ROMANIAN JOURNAL OF LEGAL MEDICINE | 2016年 / 24卷 / 02期
关键词
HIV; IDUs; late presentation; MYCOBACTERIUM-TUBERCULOSIS; COINFECTION; DIAGNOSIS; PREVALENCE; DISEASE;
D O I
10.4323/rjlm.2016.122
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Background. HIV-infected injecting drug users (HIV-IDUs) are a major challenge to the Romanian healthcare system due to their high morbidity, mortality and health-care costs. Objective. The aim of this study was to determine the prevalence of late presenters (LP) among HIV-IDUs admitted to "Victor Babes" Clinical Hospital for Infectious Diseases, Bucharest and to evaluate their demographic and clinical characteristics. Methods. We performed a prospective study on HIV-IDUs diagnosed with severe immunosuppression, admitted between January 2009 and December 2014. HIV-IDUs with CD4 cell counts <350/mm(3) were considered LP and those with CD4 to a tertiary facility <200/mm(3) were defined with advanced HIV disease (AHD). These two groups were compared to a group of the HIV-IDUs that was diagnosed early in the evolution of illness (CD4 cell count >350/mm(3)). Statistical analysis was performed using SPSS v 20.0. Results. Out of 495 HIV-IDUs admitted during the study period, 238 (48.0%) were LP and 168 (33.7%) had AHD. The proportion of LP increased from 37.5% in 2009 to 52.6% in 2014 (0<0.001). Almost all HIV-IDUs, regardless of CD4 cell count, were young males (413, 83.4%), from urban areas (453, 91.5%), unemployed (393, 79.3%) and with low educational level (381, 76.9%). The median age at drug use initiation of 19 years (IQR 16-24) and the median duration of drug use at 9 years (IQR 4-13), were similar in both groups. More than half of all HIV-IDUs initially used intravenous heroin and afterwards legal highs (339, 68.4%) and (81, 16.3%) used only legal highs. The median CD4 cell count for the LPs was 104 cells/mm(3) (IQR 24-220) and the median HIV viral load 5.44 log10 copies/mL (IQR 5.00-6.00). Compared to early diagnosed HIV-IDUs (257), late presenters were more frequently diagnosed with opportunistic infections, especially tuberculosis (117, 49.1%) vs. (37, 14.3%), p<0.0001 and severe bacterial infections, mainly respiratory (54, 22.6%) vs. (46, 17.8%) p=0.02. Mortality was higher in LPs versus early presenters IDU (7, 2.7%) vs. (54, 22.6%) respectively p<0.0001. Conclusions. The proportion of LPs among HIV-IDUs diagnosed in our hospital increased alarmingly over the last few years. There were no significant differences regarding socio-demographic characteristics and drug use behaviour between late presenters and those diagnosed early, but LPs were more often diagnosed with opportunistic infections and had a significantly higher mortality rate.
引用
收藏
页码:122 / 127
页数:6
相关论文
共 50 条
  • [21] Gender differences in health status and care among HIV-infected minority drug users
    Kang, Sung-Yeon
    Goldstein, Marjorie F.
    Deren, Sherry
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2008, 20 (09): : 1146 - 1151
  • [22] Differences in HIV disease progression by injecting drug use in HIV-infected persons in care
    Moore, RD
    Keruly, JC
    Chaisson, RE
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (01) : 46 - 51
  • [23] The prevention and care of HIV-infected drug users in contemporary Brazil
    Bastos, Francisco I.
    [J]. SUBSTANCE USE & MISUSE, 2006, 41 (6-7) : 833 - 834
  • [24] Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment
    Moatti, JP
    Carrieri, MP
    Spire, B
    Gastaut, JA
    Cassuto, JP
    Moreau, J
    [J]. AIDS, 2000, 14 (02) : 151 - 155
  • [25] HIV-INFECTED HEALTH-CARE WORKERS - RISK TO PATIENTS - REPLY
    MISHU, B
    SCHAFFNER, W
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (13): : 1545 - 1546
  • [26] SUPPORTING HEALTH-CARE WORKERS IN THE TREATMENT OF HIV-INFECTED PATIENTS
    COOKE, M
    [J]. PRIMARY CARE, 1992, 19 (01): : 245 - 256
  • [27] Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy
    Tang, AM
    Smit, E
    Semba, RD
    Shah, N
    Lyles, CM
    Li, DG
    Vlahov, D
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 23 (04): : 321 - 326
  • [28] Lack of a pharmacologic interaction between rifabutin and methadone in HIV-infected former injecting drug users
    Brown, LS
    Sawyer, RC
    Li, R
    Cobb, MN
    Colborn, DC
    Narang, PK
    [J]. DRUG AND ALCOHOL DEPENDENCE, 1996, 43 (1-2) : 71 - 77
  • [29] The moderator effect of retention in care on late presentation in HIV-infected patients
    Li, Ming-Chi
    Ko, Nai-Ying
    Wang, Liang-Yi
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2020, 32 (01): : 93 - 97
  • [30] Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users
    Turner, BJ
    Laine, C
    Cosler, L
    Hauck, WW
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 (04) : 248 - 257